Geneva, Switzerland - 13 Dec - 16 Dec 2018 The ESMO Immuno-Oncology Congress, page-47

errrr yeah.

I would not expect any major announcement about Her-Vaxx to come from Dr T. He is a recent addition to the IMU SAB and had no involvement in the development of Her-Vaxx.

He would only mention Her-Vaxx trial results if Imugene/Prof W have made an Announcement before his presentation.

Prof W invented Her-Vaxx. I really think her presentation at the Conference in SF is where you will hear detailed info about the Phase 1b trial - not Dr T's upcoming talk.

Of course Leslie has said that "Top Line Results" will be released this month - so we can reasonably expect to hear something this week or next, and if it happens before Dr T makes his talk then he may reference it - but the real news this month will be whatever Announcement comes from Imugene as a follow up too Leslie's earlier comment about Top Line results..

Best wishes

Dave